Related Experiment Video
Updated: Mar 9, 2026
Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
Published on: August 12, 2015
MLN4924 suppresses the BRCA1 complex and synergizes with PARP inhibition in NSCLC cells
Zong-Pei Guo1, Ying-Chun Hu1, Yu Xie2
1Department of Radiation Toxicology and Oncology, Beijing Key Laboratory for Radiobiology, Beijing Institute of Radiation Medicine, Beijing, 100850, PR China.
Abstract:
Like ubiquitination, several studies have demonstrated that neddylation is implicated to be involved in the double strand break repair. BRCA1 is one of the key repair factors in the homologous recombination repair and may play a downstream role of the neddylation. BRCA1 is also a frequently mutated gene in cancers, which serve as the targets for PARP inhibitors. Here we further investigated the correlation between neddylation and BRCA1 complex using neddylation inhibitor MLN4924. MLN4924 efficiently inhibited the recruitment of components of BRCA1 complex to DNA damage sites. Thus MLN4924 may collaborate with PARP inhibitor to suppress tumor. Our results showed that combination MLN4924 and PARP inhibitor Olaparib impaired the DNA repair process in NSCLC cells. Furthermore, MLN4924 and Olaparib significantly inhibited the cancer cell growth. Kaplan-Meier survival analysis from lung cancer patients showed that high expression of NEDD8, BRCA1 and PARPs correlate with worse overall survival. Thus the combination of MLN4924 and PARP inhibitor may serve as a new strategy for NSCLC treatment.
Insights
Neddylation inhibition via MLN4924 impairs DNA repair and cancer cell growth, potentially enhancing PARP inhibitors for treating non-small cell lung cancer (NSCLC). This combination may offer a novel therapeutic strategy.
Area of Science:
- Molecular Biology
- Cancer Research
- Genetics
Background:
- Neddylation, similar to ubiquitination, is involved in DNA double-strand break repair.
- BRCA1, a key homologous recombination repair factor, may function downstream of neddylation.
- BRCA1 mutations are common in cancers, making it a target for PARP inhibitors.
Purpose of the Study:
- To investigate the correlation between neddylation and the BRCA1 complex.
- To evaluate the potential of combining neddylation inhibition with PARP inhibition for cancer treatment.
Main Methods:
- Utilized the neddylation inhibitor MLN4924 to study its effects on the BRCA1 complex.
- Assessed the impact of MLN4924 and the PARP inhibitor Olaparib on DNA repair in non-small cell lung cancer (NSCLC) cells.
- Analyzed Kaplan-Meier survival data from lung cancer patients.
Main Results:
- MLN4924 inhibited the recruitment of BRCA1 complex components to DNA damage sites.
- The combination of MLN4924 and Olaparib impaired DNA repair processes in NSCLC cells.
- Combined treatment significantly inhibited cancer cell growth.
- High expression of NEDD8, BRCA1, and PARPs correlated with worse overall survival in lung cancer patients.
Conclusions:
- Neddylation inhibition may synergize with PARP inhibitors to suppress tumors.
- The combination of MLN4924 and Olaparib shows promise as a new therapeutic strategy for NSCLC.
More Related Videos
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
07:23Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:23Abnormal Proliferation
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:19Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
01:12Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...